User profiles for Marcela Salomao
Marcela SalomaoMayo Clinic Verified email at mayo.edu Cited by 2657 |
Protein 4.1 R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane
M Salomao, X Zhang, Y Yang, S Lee… - Proceedings of the …, 2008 - National Acad Sciences
Protein 4.1R (4.1R) is a multifunctional component of the red cell membrane. It forms a
ternary complex with actin and spectrin, which defines the nodal junctions of the membrane-…
ternary complex with actin and spectrin, which defines the nodal junctions of the membrane-…
Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH
M Salomao, MY Woojin, RS Brown Jr… - The American journal …, 2010 - journals.lww.com
In explant livers with chronic hepatitis C (HCV-C) we have noted a distinctive histologic
variant that we have termed steatohepatitic hepatocellular carcinoma (SH-HCC) with features …
variant that we have termed steatohepatitic hepatocellular carcinoma (SH-HCC) with features …
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Fibrosis is the major determinant of morbidity and mortality in patients with nonalcoholic
steatohepatitis (NASH) but has no approved pharmacotherapy in part because of incomplete …
steatohepatitis (NASH) but has no approved pharmacotherapy in part because of incomplete …
The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis
Steatohepatitis and metabolic syndrome are increasingly recognized as important risk factors
for development of hepatocellular carcinoma. We have recently described a histologic …
for development of hepatocellular carcinoma. We have recently described a histologic …
[HTML][HTML] Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience
TT DeLeon, MA Salomao, BA Aqel… - Journal of …, 2018 - ncbi.nlm.nih.gov
Background Patients with solid organ transplants (SOTs) have been excluded from programmed
death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitor clinical trials due …
death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitor clinical trials due …
Pembrolizumab in combination with neoadjuvant chemoradiotherapy for patients with resectable adenocarcinoma of the gastroesophageal junction
…, NR Foster, C Hartley, T Mounajjed, MA Salomao… - Clinical Cancer …, 2022 - AACR
Purpose: This phase Ib/2 trial investigated pembrolizumab-containing trimodality therapy in
patients with gastroesophageal junction (GEJ) adenocarcinoma. Patients and Methods: …
patients with gastroesophageal junction (GEJ) adenocarcinoma. Patients and Methods: …
Needle-shaped ultrathin piezoelectric microsystem for guided tissue targeting via mechanical sensing
Needles for percutaneous biopsies of tumour tissue can be guided by ultrasound or computed
tomography. However, despite best imaging practices and operator experience, high …
tomography. However, despite best imaging practices and operator experience, high …
Silk embolic material for catheter‐directed endovascular drug delivery
Embolization is a catheter‐based minimally invasive procedure that deliberately occludes
diseased blood vessels for treatment purposes. A novel silk‐based embolic material (SEM) …
diseased blood vessels for treatment purposes. A novel silk‐based embolic material (SEM) …
Bioactive‐tissue‐derived nanocomposite hydrogel for permanent arterial embolization and enhanced vascular healing
Transcatheter embolization is a minimally invasive procedure that uses embolic agents to
intentionally block diseased or injured blood vessels for therapeutic purposes. Embolic agents …
intentionally block diseased or injured blood vessels for therapeutic purposes. Embolic agents …
Histopathology of graft-vs-host disease of gastrointestinal tract and liver: an update
Objectives: Graft-vs-host disease (GVHD) is a donor T-cell-mediated disorder affecting the
recipient’s skin, gastrointestinal tract, lungs, and liver. It complicates up to 70% of …
recipient’s skin, gastrointestinal tract, lungs, and liver. It complicates up to 70% of …